Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$5.64 - $9.8 $1.52 Million - $2.65 Million
-270,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$11.32 - $16.63 $339,600 - $498,899
30,000 Added 12.5%
270,000 $3.08 Million
Q4 2020

Feb 16, 2021

BUY
$9.12 - $14.49 $273,600 - $434,700
30,000 Added 14.29%
240,000 $3.24 Million
Q3 2020

Nov 16, 2020

BUY
$10.46 - $14.46 $627,600 - $867,600
60,000 Added 40.0%
210,000 $2.47 Million
Q2 2020

Aug 14, 2020

BUY
$12.0 - $16.13 $360,000 - $483,899
30,000 Added 25.0%
150,000 $2.21 Million
Q3 2019

Nov 14, 2019

BUY
$18.41 - $28.0 $184,100 - $280,000
10,000 Added 9.09%
120,000 $2.31 Million
Q2 2019

Aug 14, 2019

BUY
$28.97 - $48.21 $434,550 - $723,150
15,000 Added 15.79%
110,000 $3.25 Million
Q4 2018

Feb 14, 2019

BUY
$33.0 - $60.04 $2.15 Million - $3.9 Million
65,000 Added 216.67%
95,000 $3.43 Million
Q3 2018

Nov 14, 2018

BUY
$56.15 - $73.9 $1.68 Million - $2.22 Million
30,000 New
30,000 $1.85 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Altrinsic Global Advisors LLC Portfolio

Follow Altrinsic Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.